Xcelience’s Scientific Director selected to lead key sessions on upcoming conferences

Tampa, FL October 31, 2007 – Dr. Steve J. Bannister, Scientific Director and Principal Consultant for leading Tampa-based CRO Xcelience, will be moderating the “Innovation and Success Strategies – Learning and Un-learning from Key Players” panel at the New Directions for Drug Delivery Conference on October 29 in Las Vegas, Nevada.

Dr. Bannister will be conducting a panel of key industry leaders from prolific companies LifeTech Innovations, MicroCHIPS, Durect and McDonnel Boehnen Hulbert & Berghoff, who will be sharing their insights on innovations and growth in today’s drug delivery business.

Steve Bannister, a much sought after expert with over two decades of experience in pharmaceutical development, will also be the chairperson for “Challenging the Science – Lighting the Path”, the opening session of the 2008 Global Cancer Conference in Tampa on January 28, 2008.

About Xcelience
Xcelience is the premier source for unsurpassed quality in drug development services. The company brings together the industry's most experienced and talented scientists, consistently and efficiently moving compounds through the research and development continuum to regulatory approval.
Since 1997, the Tampa-based laboratory has been developing formulations for clients throughout the pharmaceutical industry. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab.
The lab uses only state-of-the-art equipment, highlighted by the patented Xcelodose® which fills API directly to capsules (Xcelodose® is a registered trademark of Capsugel). This and other technologies give Xcelience unparalleled speed to market without compromising its absolute commitment to quality.
Located less than five-minutes from Tampa International Airport, both labs are close to accommodations, and convenient for clients with time-sensitive needs.
www.xcelience.com